University of Minnesota Masonic Cancer Center Logo
Print this page.Mail this link to a friend.

Find a Clinical Trial


Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Multiple Myeloma Clinical Trials

Protocol Number Title
1999LS060
 MT1999-14 Unrelated or partially matched allogeneic donor stem cells for lymphoma, myeloma, and chronic lymphocytic leukemia
2000LS040
 MT2000-12 Busulfan, Cyclophosphamide, and Melphalan Followed by Allogeneic Hematopoietic Cell Transplantation in Patients with Hematological Malignancies
2001LS058
 MT2001-10 Allogeneic Bone Marrow Transplant Using Less Intensive Therapy
2002LS032
 MT1999-06: Vaccination with Tetanus Toxoid and Keyhold Limpet Hemocyanin (KLH) to Assess Antigen-Specific Immune Responses
2004LS001
 MT2003-13 Autologous Transplantation for Multiple Myeloma
2004LS006
 MT2003-15 Use of Cyclophosphamide/Fludarabine to Promote in vivo Expansion of Donor Lymphocyte Infusion s(DLI) to Enhance Efficacy after Allogeneic Transplant
2004LS034
 MT2004-03: A Dose Escalation Study of CD4+ CD25+ Cells in Adult Patients Undergoing HLA-Identical Sibling Donor Peripheral Blood Progenitor Cell (PBPC) Transplantation" MT2004-03: A Clinical Trial of Adult CD4+ CD25+ Regulatory T Cells in BMT Recipients
2005LS036
 MT2005-02: Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
2005LS043
 MT2005-10: Transplantation of Unrelated Umbilical Cord Blood for Patients with Hematological Diseases with Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloblative Preparative Regimen
2007NT123
 2007-18R: Chronic GVHD Cohort Protocol
2008LS035
 Phase I-II Trial of Genistein in Subjects Receiving Palliative External Beam Radiation Therapy for Osseous Metastases: A Study of Palliation of Symptoms and Quality of Life
2008LS139
 MT2008-38: A Phase I Trial to Determine Safety and Tolerability of Ex Vivo Expanded Human Myeloid Progenitor Cells (CLT-008) Infused 24 Hours Post-Transplant to Support Allogeneic Umbilical Cord Blood Transplantation for Hematologic Malignancies
2009NTCG002
 Pilot Study of Financial impact of Allogeneic Stem Cell Transplant

13 trials displayed